GC Biopharma Shares Research Updates on Rare Disorder Drugs at the WORLD Symposium 2025

GC Biopharma Shares Research Updates on Rare Disorder Drugs at the WORLD Symposium 2025

YONGIN, South Korea , Feb. 11, 2025 /PRNewswire/ -- GC Biopharma, a South Korean biopharmaceutical company, announced on Feb. 10th that it presented development updates on its LSD (lysosomal storage disorder) pipelines at the WORLD Symposium 2025,...

menu
menu